Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban versus acenocoumarol for secondary prophylaxis in antiphospholipid syndrome
2010-019764-36Phase 3Completed
- Sponsor
- JOSEP ORDI-ROS
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of rivaroxaban in antiphospholipid syndrome (APS) (2 arms), sponsored by JOSEP ORDI-ROS. Started Nov 2010; status: completed.
02
Drugs
rivaroxaban
03
Conditions
antiphospholipid syndrome (APS)
Beyond the preview
Go deeper on 2010-019764-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019764-36.